Skip to main content

and
  1. No Access

    Article

    Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis

    There is limited data regarding the role for systemic treatment in patients with Hepatocellular Carcinoma with Child–Pugh B cirrhosis.

    Jean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki in Hepatology International (2021)

  2. No Access

    Article

    Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?

    The abscopal effect, which is the spontaneous regression of tumors or metastases outside the radiation field, occurs rarely in cancer patients. Interestingly, radiotherapy (RT) triggers an immunogenic cell dea...

    Gaël Deplanque, Keyvan Shabafrouz, Michel Obeid in Cancer Immunology, Immunotherapy (2017)

  3. Article

    Open Access

    Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event

    Cetuximab is a commonly used antibody agent in the treatment of colorectal or head and neck cancer. Although it is generally well tolerated in most patients, cetuximab has been associated with some rare but se...

    Christophe Maritaz, Carole Metz, Nabil Baba-Hamed, Méryam Jardin-Szucs in BMC Cancer (2016)

  4. No Access

    Article

    Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

    To evaluate the efficacy and safety of masitinib combined with gemcitabine in patients with advanced pancreatic cancer.

    Emmanuel Mitry, Pascal Hammel, Gaël Deplanque in Cancer Chemotherapy and Pharmacology (2010)

  5. No Access

    Article

    Cancer du sein métastatique

    Si la prise en charge du cancer du sein précoce est relativement bien codifiée, il n’en est pas de même pour le cancer du sein métastatique où les attitudes sont extrêmement variables. Les recommandations édic...

    Mario Campone, Gaël Deplanque, Nadine Dohollou, Joseph Gligorov in Oncologie (2008)

  6. No Access

    Article

    Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function

    Abstract

    Jocelyn Céraline, Gaël Deplanque, Francine Noël in Cancer Chemotherapy and Pharmacology (2003)